Literature DB >> 2596572

Endothelial-cell injury in cutaneous acute graft-versus-host disease.

J S Dumler1, W E Beschorner, E R Farmer, K A Di Gennaro, R Saral, G W Santos.   

Abstract

The presence of an erythematous skin rash and hemorrhagic complications in acute graft-versus-host disease (GVHD) suggest that the vasculature may be involved in the immunopathologic process. We reviewed endothelial and vascular histopathologic changes on light microscopy and on immunoperoxidase stained sections of skin biopsies obtained from 41 HLA-identical allogeneic marrow transplant recipients with at least grade 2 GVHD. Biopsies taken from 14 allogeneic HLA-identical bone marrow transplant recipients who never developed GVHD were used as controls. Sections were evaluated for evidence of immunologic vascular injury using the rank file analysis of histologic features, expression of HLA-DR antigen, and the distribution of fibrin and factor VIII-related antigen (F VIII RAg). Patients with acute GVHD had significantly greater intimal lymphocytic infiltrates, perivascular nuclear dust deposition, perivascular F VIII Rag extravasation and deposition and vascular proliferation than controls. We find significantly greater endothelial injury in GVHD patients, which may represent primary immunologic injury to the vasculature. The clinical findings in acute GVHD probably result from cumulative endothelial as well as epithelial injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596572      PMCID: PMC1880480     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells.

Authors:  B Ferry; J Halttunen; D Leszczynski; H Schellekens; P H vd Meide; P Häyry
Journal:  Transplantation       Date:  1987-10       Impact factor: 4.939

2.  The skin biopsy in the diagnosis of acute graft-versus-host disease in man.

Authors:  G E Sale; K G Lerner; E A Barker; H M Shulman; E D Thomas
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

3.  Subsets of T cells in the rat mediating lethal graft versus-host disease.

Authors:  D W Mason
Journal:  Transplantation       Date:  1981-09       Impact factor: 4.939

4.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

5.  Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium.

Authors:  D W Mason; M Dallman; A N Barclay
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

6.  An increased factor VIII antigen as an indicator of endothelial damage in measles.

Authors:  R Corda; M Alberti; L Caocci; G Putzolu; P M Mannucci
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  Endothelial proliferation in the delayed hypersensitivity reaction: an autoradiographic study.

Authors:  P J Polverini; R S Cotran; M M Sholley
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

Review 8.  Graft-v-host disease.

Authors:  W D James; R B Odom
Journal:  Arch Dermatol       Date:  1983-08

9.  Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.

Authors:  Y A Sidky; R Auerbach
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.

Authors:  H F Dvorak; M C Mihm; A M Dvorak; B A Barnes; E J Manseau; S J Galli
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Di-Min Nie; Qiu-Ling Wu; Xia-Xia Zhu; Ran Zhang; Peng Zheng; Jun Fang; Yong You; Zhao-Dong Zhong; Ling-Hui Xia; Mei Hong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 3.  Venous thromboembolism in hematopoietic stem cell transplant recipients.

Authors:  S Chaturvedi; A Neff; A Nagler; U Savani; M Mohty; B N Savani
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

4.  CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients.

Authors:  Y Koike; S Seki; T Ohkawa; T Kaneko; K Kogawa; S Fujitsuka; H Hiraide; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

5.  Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Jorge Labrador; Lucia Lopez-Anglada; Estefania Perez-Lopez; Francisco S Lozano; Lucia Lopez-Corral; Fermin M Sanchez-Guijo; Lourdes Vazquez; Jose Angel Perez Rivera; Francisco Martin-Herrero; Mercedes Sanchez-Barba; Carmen Guerrero; Maria Consuelo del Cañizo; Maria Dolores Caballero; Jesus Fernando San Miguel; Ignacio Alberca; Jose Ramon Gonzalez-Porras
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

6.  Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease.

Authors:  J Norton; J P Sloane; N al-Saffar; D O Haskard
Journal:  J Clin Pathol       Date:  1991-07       Impact factor: 3.411

7.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Peripheral tolerance can be modified by altering KLF2-regulated Treg migration.

Authors:  Sudheer K Pabbisetty; Whitney Rabacal; Emmanuel J Volanakis; Vrajesh V Parekh; Danyvid Olivares-Villagómez; Delphine Cendron; Kelli L Boyd; Luc Van Kaer; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-26       Impact factor: 11.205

Review 9.  Transplant-associated thrombotic microangiopathy: opening Pandora's box.

Authors:  E Gavriilaki; I Sakellari; A Anagnostopoulos; R A Brodsky
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

10.  A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Authors:  Haruka Nomoto; Akiyoshi Takami; J Luis Espinoza; Keitaro Matsuo; Shohei Mizuno; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Shinji Nakao; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2015-08-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.